The complexities of malaria disease manifestations with a focus on asymptomatic malaria

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Laishram, Dolie D ^a,c   Sutton, Patrick L ^b   Nanda, Nutan ^a   Sharma, Vijay L ^c   Sobti, Ranbir C ^c   Carlton, Jane M ^b   Joshi, Hema ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^b NEW YORK UNIVERSITY   (United States)

^c PANJAB UNIVERSITY   (India)

Author keywords

Asymptomatic malaria; Host factors; Parasite factors; Transmission dynamics

Indexed keywords

ANTIGEN; ANTIMALARIAL AGENT; APICAL MEMBRANE ANTIGEN 1; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CYTOKINE; ERYTHROCYTE BINDING ANTIGEN 175; HOST FACTOR; IMMUNOGLOBULIN; INSECTICIDE; MEFLOQUINE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE; UNCLASSIFIED DRUG; PARASITE ANTIGEN;

ASYMPTOMATIC MALARIA; DISEASE CONTROL; DISEASE SEVERITY; ERYTHROCYTE; GAMETOCYTE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNITY; MALARIA; MALARIA FALCIPARUM; MORBIDITY; MORTALITY; MOSQUITO; NONHUMAN; OUTCOME ASSESSMENT; PARASITE; PARASITEMIA; PLASMODIUM; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; PREGNANCY; PREVALENCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VIRULENCE; AFRICA; ANIMAL; ASIA; ASYMPTOMATIC DISEASE; DISEASE CARRIER; FEMALE; HOSPITALIZATION; HOST PARASITE INTERACTION; IMMUNOLOGY; PARASITOLOGY; PATHOPHYSIOLOGY; SOUTH AND CENTRAL AMERICA;

AFRICA; ANIMALS; ANTIGENS, PROTOZOAN; ASIA; ASYMPTOMATIC DISEASES; FEMALE; HOST-PARASITE INTERACTIONS; HUMANS; INSECT VECTORS; LATIN AMERICA; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PREGNANCY; SEVERITY OF ILLNESS INDEX;

EID: 84856327673     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-29     Document Type: Review

References (177)

1. WHO, Annual Report Geneva: World Health Organization 2008
2. Demographic effects of malaria with special reference to the stable malaria of Africa. McGregor IA, West Afr Med J 1960 81 260 265
3. Indicators of life-threatening malaria in African children. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Warn P, Peshu N, Pasvol G, Snow R, N Engl J Med 1995 332 1399 1404 10.1056/NEJM199505253322102 7723795
4. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. WHO, Trans R Soc Trop Med Hyg 2000 94 Suppl 1 1 S90 11103309
5. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Snow RW, Omumbo JA, Lowe B, Molyneux CS, Obiero JO, Palmer A, Weber MW, Pinder M, Nahlen B, Obonyo C, Newbold C, Gupta S, Marsh K, Lancet 1997 349 1650 1654 10.1016/S0140-6736(97) 02038-2 9186382 (Pubitemid 27234806)
6. Uncomplicated malaria. Grobusch MP, Kremsner PG, Curr Top Microbiol Immunol 2005 295 83 104 16265888 (Pubitemid 41236512)
7. Immunity to non-cerebral severe malaria is acquired after one or two infections. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C, Nat Med 1999 5 340 343 10.1038/6560 10086393 (Pubitemid 29124373)
8. Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction. Bottius E, Guanzirolli A, Trape JF, Rogier C, Konate L, Druilhe P, Trans R Soc Trop Med Hyg 1996 90 15 19 10.1016/S0035-9203(96)90463-0 8730301 (Pubitemid 26069436)
9. Assessment of the incidence and prevalence of clinical malaria in semi-immune children exposed to intense and perennial transmission. Trape JF, Zoulani A, Quinet MC, Am J Epidemiol 1987 126 193 201 10.1093/aje/126.2.193 3605048 (Pubitemid 17102747)
10. Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. Daubersies P, Sallenave-Sales S, Magne S, Trape JF, Contamin H, Fandeur T, Rogier C, Mercereau-Puijalon O, Druilhe P, Am J Trop Med Hyg 1996 54 18 26 8651363 (Pubitemid 26045727)
11. Naturally acquired immunity to Plasmodium falciparum. Day KP, Marsh K, Immunol Today 1991 12 68 A71 10.1016/S0167-5699(05)80020-9 2069680
12. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Trape JF, Rogier C, Konate L, Diagne N, Bouganali H, Canque B, Legros F, Badji A, Ndiaye G, Ndiaye P, Brahimi K, Faye O, Druilhe P, Da Silva LP, Am J Trop Med Hyg 1994 51 123 137 8074247 (Pubitemid 24324732)
13. The epidemiology of malaria in an epidemic area of the Peruvian Amazon. Roper MH, Torres RS, Goicochea CG, Andersen EM, Guarda JS, Calampa C, Hightower AW, Magill AJ, Am J Trop Med Hyg 2000 62 247 256 10813480 (Pubitemid 30257585)
14. Asymptomatic carriers of Plasmodium sp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. Alves FP, Gil LH, Marrelli MT, Ribolla PE, Camargo EP, Da Silva LH, J Med Entomol 2005 42 777 779 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2 16363160 (Pubitemid 41375483)
15. Endemic malaria in the Peruvian Amazon region of Iquitos. Roshanravan B, Kari E, Gilman RH, Cabrera L, Lee E, Metcalfe J, Calderon M, Lescano AG, Montenegro SH, Calampa C, Vinetz JM, Am J Trop Med Hyg 2003 69 45 52 12932096
16. Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Branch O, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, Alvarez E, Perez EJ, Gotuzzo E, Malar J 2005 4 27 10.1186/1475-2875-4- 27 15975146 (Pubitemid 41214251)
17. Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil. Cerutti C Jr, Boulos M, Coutinho AF, Hatab Mdo C, Falqueto A, Rezende HR, Duarte AM, Collins W, Malafronte RS, Malar J 2007 6 33 10.1186/1475-2875-6-33 17371598 (Pubitemid 46512736)
18. Molecular screening of Plasmodium sp. asymptomatic carriers among transfusion centers from Brazilian Amazon region. Fugikaha E, Fornazari PA, Penhalbel Rde S, Lorenzetti A, Maroso RD, Amoras JT, Saraiva AS, Silva RU, Bonini-Domingos CR, Mattos LC, Rossit AR, Cavasini CE, Machado RL, Rev Inst Med Trop Sao Paulo 2007 49 1 4 17384812 (Pubitemid 46475127)
19. Asymptomatic Plasmodium sp. infection in Tierralta, Colombia. Cucunuba ZM, Guerra AP, Rahirant SJ, Rivera JA, Cortes LJ, Nicholls RS, Mem Inst Oswaldo Cruz 2008 103 668 673 19057816
20. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, Boaz L, Lilley K, Krause D, Vallely A, Johnson ML, Gatton ML, Shanks GD, Cheng Q, Malar J 2010 9 254 10.1186/1475-2875-9-254 20822506
21. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LH, Camargo EP, Am J Trop Med Hyg 2002 66 641 648 12224567 (Pubitemid 35001032)
22. Cross sectional study reveals a high percentage of asymptomatic Plasmodium vivax infection in the Amazon Rio Negro area, Brazil. Suarez-Mutis MC, Cuervo P, Leoratti FM, Moraes-Avila SL, Ferreira AW, Fernandes O, Coura JR, Rev Inst Med Trop Sao Paulo 2007 49 159 164 17625693 (Pubitemid 47041689)
23. Transfusion-transmitted malaria: case report of asymptomatic donor harboring Plasmodium malariae. Scuracchio P, Vieira SD, Dourado DA, Bueno LM, Colella R, Ramos-Sanchez EM, Lima GF, Inoue J, Sanchez MC, Di Santi SM, Rev Inst Med Trop Sao Paulo 2011 53 55 59 10.1590/S0036-46652011000100010 21412621
24. Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. Vinetz JM, Li J, McCutchan TF, Kaslow DC, N Engl J Med 1998 338 367 371 10.1056/NEJM199802053380605 9449730 (Pubitemid 28083909)
25. Plasmodium ovale infection: description of 16 cases and a review. Rojo-Marcos G, Cuadros-Gonzalez J, Gete-Garcia L, Gomez-Herruz P, Lopez-Rubio M, Esteban-Gutierrez G, Enferm Infecc Microbiol Clin 2011 29 204 208 10.1016/j.eimc.2010.09.004 21342729
26. A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection - a review. Coura JR, Suarez-Mutis M, Ladeia-Andrade S, Mem Inst Oswaldo Cruz 2006 101 229 237 16862314 (Pubitemid 43962006)
27. Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. de Mast Q, Syafruddin D, Keijmel S, Olde Riekerink T, Deky O, Asih PB, Swinkels DW, van der Ven AJ, Haematologica 2010 95 1068 1074 10.3324/haematol.2009.019331 20133896
28. Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria. Leoratti FM, Durlacher RR, Lacerda MV, Alecrim MG, Ferreira AW, Sanchez MC, Moraes SL, Malar J 2008 7 186 10.1186/1475-2875-7-186 18816374
29. Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children. Males S, Gaye O, Garcia A, Clin Infect Dis 2008 46 516 522 10.1086/526529 18199040 (Pubitemid 351263488)
30. Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status. Duarte J, Deshpande P, Guiyedi V, Mecheri S, Fesel C, Cazenave PA, Mishra GC, Kombila M, Pied S, Malar J 2007 6 1 10.1186/1475-2875-6-1 17204149 (Pubitemid 46169626)
31. Microsatellite characterization of Plasmodium falciparum from symptomatic and non-symptomatic infections from the Western Amazon reveals the existence of non-symptomatic infection-associated genotypes. dalla Martha RC, Tada MS, Ferreira RG, da Silva LH, Wunderlich G, Mem Inst Oswaldo Cruz 2007 102 293 298 10.1590/S0074-02762007005000044 17568933 (Pubitemid 46869325)
32. Imbalanced distribution of Plasmodium falciparum EBA-175 genotypes related to clinical status in children from Bakoumba, Gabon. Toure FS, Bisseye C, Mavoungou E, Clin Med Res 2006 4 7 11 10.3121/cmr.4.1.7 16595788
33. Differential expression of var gene groups is associated with morbidity caused by Plasmodium falciparum infection in Tanzanian children. Rottmann M, Lavstsen T, Mugasa JP, Kaestli M, Jensen AT, Muller D, Theander T, Beck HP, Infect Immun 2006 74 3904 3911 10.1128/IAI.02073-05 16790763 (Pubitemid 43993322)
34. High Prevalence of asymptomatic Plasmodium infection in a Suburb of Aba Town, Nigeria. Eke RA, Chigbu LN, Nwachukwu W, Ann Afr Med 2006 5 42 45 (Pubitemid 44488872)
35. High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults. Dal-Bianco MP, Koster KB, Kombila UD, Kun JF, Grobusch MP, Ngoma GM, Matsiegui PB, Supan C, Salazar CL, Missinou MA, Issifou S, Lell B, Kremsner P, AmJTrop Med Hyg 2007 77 939 942 (Pubitemid 351837845)
36. High prevalence of asymptomatic malaria in gold mining areas in Brazil. de Andrade AL, Martelli CM, Oliveira RM, Arias JR, Zicker F, Pang L, Clin Infect Dis 1995 20 475 10.1093/clinids/20.2.475 7742465
37. Antibodies to Plasmodium falciparum rifin proteins are associated with rapid parasite clearance and asymptomatic infections. Abdel-Latif MS, Dietz K, Issifou S, Kremsner PG, Klinkert MQ, Infect Immun 2003 71 6229 6233 10.1128/IAI.71.11.6229-6233.2003 14573641 (Pubitemid 37337679)
38. Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults. Boutlis CS, Tjitra T, Maniboey H, Misukonis MA, Saunders JR, Suprianto S, Weinberg JB, Anstey NM, Infect Immun 2003 71 3682 3689 10.1128/IAI.71.7.3682-3689.2003 12819048 (Pubitemid 36753687)
39. Spatial targeting of interventions against malaria. Carter R, Mendis KN, Roberts D, Bull World Health Organ 2000 78 1401 1411 11196487 (Pubitemid 32105024)
40. Quantifying genetic and nongenetic contributions to malarial infection in a Sri Lankan population. Mackinnon MJ, Gunawardena DM, Rajakaruna J, Weerasingha S, Mendis KN, Carter R, Proc Natl Acad Sci USA 2000 97 12661 12666 10.1073/pnas.220267997 11035799
41. Prolonged infection with Plasmodium falciparum in a semi-immune patient. Krajden S, Panisko DM, Tobe B, Yang J, Keystone JS, Trans R Soc Trop Med Hyg 1991 85 731 732 10.1016/0035-9203(91)90434-Z 1801338
42. Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Babiker HA, Abdel-Muhsin AM, Ranford-Cartwright LC, Satti G, Walliker D, Am J Trop Med Hyg 1998 59 582 590 9790434 (Pubitemid 28480715)
43. Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F, Malar J 2008 7 17 10.1186/1475-2875-7-17 18215251 (Pubitemid 351378200)
44. Relation between Plasmodium falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. Le Port A, Cot M, Etard JF, Gaye O, Migot-Nabias F, Garcia A, Malar J 2008 7 193 10.1186/1475-2875-7-193 18823542
45. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, Marsh K, Tulloch S, Oldfield FS, Hayes R, Trans R Soc Trop Med Hyg 1987 81 478 486 10.1016/0035-9203(87)90170-2 3318021
46. Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. Smith T, Charlwood JD, Kihonda J, Mwankusye S, Billingsley P, Meuwissen J, Lyimo E, Takken W, Teuscher T, Tanner M, Acta Trop 1993 54 55 72 10.1016/0001-706X(93)90068-M 8103627 (Pubitemid 23236067)
47. Immunity in malaria. Tomson G, Trans R Soc Trop Med Hyg 1933 26 483 503 10.1016/S0035-9203(33)90123-6
48. The epidemiology of malaria in Rondonia (Western Amazon region, Brazil): study of a riverine population. Camargo LM, Noronha E, Salcedo JM, Dutra AP, Krieger H, da Pereira Silva LH, Camargo EP, Acta Trop 1999 72 1 11 10.1016/S0001-706X(98)00082-5 9924956 (Pubitemid 29062918)
49. Symptomless Plasmodium vivax infections in native Amazonians. Camargo EP, Alves F, da Pereira Silva LH, Lancet 1999 353 1415 1416 10227233 (Pubitemid 29192424)
50. Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19 kD (MSP1-19 kD), in Peruvians exposed to hypoendemic malaria transmission. Torres KJ, Clark EH, Hernandez JN, Soto-Cornejo KE, Gamboa D, Branch OH, Malar J 2008 7 173 10.1186/1475-2875-7-173 18782451
51. A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali. Weiss GE, Clark EH, Li S, Traore B, Kayentao K, Ongoiba A, Hernandez JN, Doumbo OK, Pierce SK, Branch OH, Crompton PD, PLoS One 2011 6 15983 10.1371/journal.pone.0015983 21264245
52. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, Sauerwein RW, Am J Trop Med Hyg 2007 76 470 474 17360869 (Pubitemid 351627738)
53. Aggregation in malaria parasites places limits on mosquito infection rates. Paul RE, Bonnet S, Boudin C, Tchuinkam T, Robert V, Infect Genet Evol 2007 7 577 586 10.1016/j.meegid.2007.04.004 17521970 (Pubitemid 47342376)
54. Host haematological factors influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae s.s. mosquitoes. Drakeley CJ, Secka I, Correa S, Greenwood BM, Targett GA, Trop Med Int Health 1999 4 131 138 10.1046/j.1365-3156.1999.00361.x 10206267 (Pubitemid 29133491)
55. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, Pinder M, Doherty T, Sutherland C, Walraven G, Milligan P, J Infect Dis 2001 183 1254 1259 10.1086/319689 11262208 (Pubitemid 32281565)
56. High gametocyte complexity and mosquito infectivity of Plasmodium falciparum in the Gambia. Nwakanma D, Kheir A, Sowa M, Dunyo S, Jawara M, Pinder M, Milligan P, Walliker D, Babiker HA, Int J Parasitol 2008 38 219 227 10.1016/j.ijpara.2007.07.003 17709108 (Pubitemid 350266643)
57. High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. Boudin C, Olivier M, Molez JF, Chiron JP, Ambroise-Thomas P, Am J Trop Med Hyg 1993 48 700 706 8517489 (Pubitemid 23187202)
58. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Hogh B, Gamage-Mendis A, Butcher GA, Thompson R, Begtrup K, Mendis C, Enosse SM, Dgedge M, Barreto J, Eling W, Sinden RE, Am J Trop Med Hyg 1998 58 176 182 9502601 (Pubitemid 28096223)
59. Gametocytaemia and infectiousness in falciparum malaria: observations and models. Nedelman J, Adv Dis Vector Res 1989 6 59 89 10.1007/978-1-4612-3292-6-3
60. Chloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum. Hallett RL, Dunyo S, Ord R, Jawara M, Pinder M, Randall A, Alloueche A, Walraven G, Targett GA, Alexander N, Sutherland CJ, PLoS Clin Trials 2006 1 15 10.1371/journal.pctr.0010015 16871318
61. Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. Meerman L, Ord R, Bousema JT, van Niekerk M, Osman E, Hallett R, Pinder M, Walraven G, Sutherland CJ, J Infect Dis 2005 192 1651 1657 10.1086/496887 16206082 (Pubitemid 41504703)
62. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, ter Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ, AmJTrop Med Hyg 1999 60 1019 1023 (Pubitemid 29296230)
63. The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine- and pyrimethamine-treated cases. Jeffery GM, Young MD, Eyles DE, Am J Hyg 1956 64 1 11 13339773
64. Plasmodium falciparum gametocytes: their longevity and infectivity. Smalley ME, Sinden RE, Parasitology 1977 74 1 8 10.1017/S0031182000047478 320542 (Pubitemid 8016153)
65. Infectious reservoir of Plasmodium infection in Mae Hong Son Province, north-west Thailand. Pethleart A, Prajakwong S, Suwonkerd W, Corthong B, Webber R, Curtis C, Malar J 2004 3 34 10.1186/1475-2875-3-34 15385050
66. Plasmodium falciparum malaria disease manifestations in humans and transmission to Anopheles gambiae: a field study in Western Kenya. Gouagna LC, Ferguson HM, Okech BA, Killeen GF, Kabiru EW, Beier JC, Githure JI, Yan G, Parasitology 2004 128 235 243 10.1017/S003118200300444X 15074873 (Pubitemid 38437955)
67. Infectivity of Plasmodium falciparum gametocytes in patients attending rural health centres in western Kenya. Gouagna LC, Okech BA, Kabiru EW, Killeen GF, Obare P, Ombonya S, Bier JC, Knols BG, Githure JI, Yan G, East Afr Med J 2003 80 627 634 15018419 (Pubitemid 41295490)
68. The pathogenic basis of malaria. Miller LH, Baruch DI, Marsh K, Doumbo OK, Nature 2002 415 673 679 10.1038/415673a 11832955 (Pubitemid 34136400)
69. The effects of multiplication and synchronicity on the vascular distribution of parasites in falciparum malaria. White NJ, Chapman D, Watt G, Trans R Soc Trop Med Hyg 1992 86 590 597 10.1016/0035-9203(92)90141-X 1287908 (Pubitemid 23012896)
70. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Silamut K, Phu NH, Whitty C, Turner GD, Louwrier K, Mai NT, Simpson JA, Hien TT, White NJ, Am J Pathol 1999 155 395 410 10.1016/S0002-9440(10)65136-X 10433933 (Pubitemid 29370390)
71. Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children. Njama-Meya D, Kamya MR, Dorsey G, Trop Med Int Health 2004 9 862 868 10.1111/j.1365-3156.2004.01277.x 15303990 (Pubitemid 39120143)
72. Impact of Plasmodium falciparum infection on haematological parameters in children living in Western Kenya. Maina RN, Walsh D, Gaddy C, Hongo G, Waitumbi J, Otieno L, Jones D, Ogutu BR, Malar J 2010 9 Suppl 3 4 10.1186/1475-2875-9- S3-S4 21144084
73. Depression of platelet counts in apparently healthy children with asymptomatic malaria infection in a Nigerian metropolitan city. Jeremiah ZA, Uko EK, Platelets 2007 18 469 471 10.1080/09537100701194871 17763156 (Pubitemid 47347055)
74. Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Marsh K, Howard RJ, Science 1986 231 150 153 10.1126/science.2417315 2417315 (Pubitemid 16154704)
75. Seasonal variation in agglutination of Plasmodium falciparum-infected erythrocytes. Giha HA, Theander TG, Staalso T, Roper C, Elhassan IM, Babiker H, Satti GM, Arnot DE, Hviid L, Am J Trop Med Hyg 1998 58 399 405 9574782 (Pubitemid 28183247)
76. A strain theory of malaria transmission. Gupta S, Day KP, Parasitol Today 1994 10 476 481 10.1016/0169-4758(94)90160-0 15275516 (Pubitemid 24344391)
77. Diversity of Plasmodium falciparum populations and complexity of infections in relation to transmission intensity and host age: a study from the Usambara Mountains, Tanzania. Bendixen M, Msangeni HA, Pedersen BV, Shayo D, Bodker R, Trans R Soc Trop Med Hyg 2001 95 143 148 10.1016/S0035-9203(01)90140-3 11355544 (Pubitemid 34947371)
78. Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal. Robert F, Ntoumi F, Angel G, Candito D, Rogier C, Fandeur T, Sarthou JL, Mercereau-Puijalon O, Trans R Soc Trop Med Hyg 1996 90 704 711 10.1016/S0035-9203(96)90446-0 9015525 (Pubitemid 27011178)
79. Consequences of multiple infection with Plasmodium falciparum in an area of high endemicity. Smith T, Felger I, Beck HP, Tanner M, Parassitologia 1999 41 247 250 10697863 (Pubitemid 129640260)
80. Genetic diversity of the msp-1 locus and symptomatic malaria in south-west Nigeria. Amodu OK, Adeyemo AA, Ayoola OO, Gbadegesin RA, Orimadegun AE, Akinsola AK, Olumese PE, Omotade OO, Acta Trop 2005 95 226 232 10.1016/j.actatropica.2005.06.017 16023985 (Pubitemid 41207286)
81. Association of severe malaria with a specific Plasmodium falciparum genotype in French Guiana. Ariey F, Hommel D, Le Scanf C, Duchemin JB, Peneau C, Hulin A, Sarthou JL, Reynes JM, Fandeur T, Mercereau-Puijalon O, J Infect Dis 2001 184 237 241 10.1086/322012 11424024 (Pubitemid 32614058)
82. Complexity of the msp2 locus and the severity of childhood malaria, in south-western Nigeria. Amodu OK, Oyedeji SI, Ntoumi F, Orimadegun AE, Gbadegesin RA, Olumese PE, Omotade OO, Ann Trop Med Parasitol 2008 102 95 102 10.1179/136485908X252340 18318931 (Pubitemid 351767937)
83. Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes. Engelbrecht F, Felger I, Genton B, Alpers M, Beck HP, Exp Parasitol 1995 81 90 96 10.1006/expr.1995.1096 7628572
84. Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status. Al-Yaman F, Genton B, Taraika J, Anders R, Alpers MP, Parasite Immunol 1997 19 207 214 10.1046/j.1365-3024.1997.d01-198.x 9194097 (Pubitemid 27242522)
85. Plasmodium falciparum: distribution of msp2 genotypes among symptomatic and asymptomatic individuals from the Wosera region of Papua New Guinea. Cortes A, Mellombo M, Benet A, Lorry K, Rare L, Reeder JC, Exp Parasitol 2004 106 22 29 10.1016/j.exppara.2004.01.010 15013785 (Pubitemid 38317195)
86. Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1. Cortes A, Mellombo M, Mueller I, Benet A, Reeder JC, Anders RF, Infect Immun 2003 71 1416 1426 10.1128/IAI.71.3.1416-1426.2003 12595459 (Pubitemid 36254328)
87. EBA-175: an erythrocyte-binding ligand of Plasmodium falciparum. Sim BK, Parasitol Today 1995 11 213 217 15275345
88. Primary structure and subcellular localization of the knob-associated histidine-rich protein of Plasmodium falciparum. Pologe LG, Pavlovec A, Shio H, Ravetch JV, Proc Natl Acad Sci USA 1987 84 7139 7143 10.1073/pnas.84.20.7139 3313387
89. Genetic diversity among field isolates of Plasmodium falciparum in India. Bhutani N, Ranjit MR, Yameen M, Singh N, Dev V, Pillai CR, Ansari MA, Sharma YD, Curr Sci 1998 75 160 163 (Pubitemid 128681084)
90. Distribution of Plasmodium falciparum genotypes in clinically mild and severe malaria cases in Orissa, India. Ranjit MR, Das A, Das BP, Das BN, Dash BP, Chhotray GP, Trans R Soc Trop Med Hyg 2005 99 389 395 10.1016/j.trstmh.2004. 09.010 15780346 (Pubitemid 40361569)
91. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Su XZ, Heatwole VM, Wertheimer SP, Guinet F, Herrfeldt JA, Peterson DS, Ravetch JA, Wellems TE, Cell 1995 82 89 100 10.1016/0092-8674(95) 90055-1 7606788
92. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, Peterson DS, Pinches R, Newbold CI, Miller LH, Cell 1995 82 101 110 10.1016/0092-8674(95)90056-X 7606775
93. Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study. Kaestli M, Cockburn IA, Cortes A, Baea K, Rowe JA, Beck HP, J Infect Dis 2006 193 1567 1574 10.1086/503776 16652286 (Pubitemid 43794587)
94. Differential va gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Kyriacou HM, Stone GN, Challis RJ, Raza A, Lyke KE, Thera MA, Kone AK, Doumbo OK, Plowe CV, Rowe JA, Mol Biochem Parasitol 2006 150 211 218 10.1016/j.molbiopara.2006.08.005 16996149 (Pubitemid 44691950)
95. Association of severe noncerebral Plasmodium falciparum malaria in Brazil with expressed PfEMP1 DBL1 alpha sequences lacking cysteine residues. Kirchgatter K, del Portillo HA, Mol Med 2002 8 16 23 11984002 (Pubitemid 34451117)
96. Plasmodium falciparum variant surface antigen expression patterns during malaria. Bull PC, Berriman M, Kyes S, Quail MA, Hall N, Kortok MM, Marsh K, Newbold CI, PLoS Pathog 2005 1 26 10.1371/journal.ppat.0010026 16304608
97. Clinical immunity to malaria. Schofield L, Mueller I, Curr Mol Med 2006 6 205 221 10.2174/156652406776055221 16515511
98. Immune responses to asexual blood-stages of malaria parasites. Yazdani SS, Mukherjee P, Chauhan VS, Chitnis CE, Curr Mol Med 2006 6 187 203 10.2174/156652406776055212 16515510
99. Intraleucocytic malaria pigment and clinical severity of malaria in children. Amodu OK, Adeyemo AA, Olumese PE, Gbadegesin RA, Trans R Soc Trop Med Hyg 1998 92 54 56 10.1016/S0035-9203(98)90952-X 9692152 (Pubitemid 28073730)
100. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Lyke KE, Diallo DA, Dicko A, Kone A, Coulibaly D, Guindo A, Cissoko Y, Sangare L, Coulibaly S, Dakouo B, Taylor TE, Doumbo OK, Plowe CV, Am J Trop Med Hyg 2003 69 253 259 14628940
101. Intraleucocytic malaria pigment and prognosis in severe malaria. Nguyen PH, Day N, Pram TD, Ferguson DJ, White NJ, Trans R Soc Trop Med Hyg 1995 89 200 204 10.1016/0035-9203(95)90496-4 7778149
102. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D, Nature 1994 371 508 510 10.1038/371508a0 7935762
103. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Fernandez-Reyes D, Craig AG, Kyes SA, Peshu N, Snow RW, Berendt AR, Marsh K, Newbold CI, Hum Mol Genet 1997 6 1357 1360 10.1093/hmg/6.8.1357 9259284 (Pubitemid 27351078)
104. Hill, Weatherall, In Malaria: Parasite Biology Pathogenesis and Protection Washington: ASM 1998
105. Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambarene, Gabon. Kun JF, Klabunde J, Lell B, Luckner D, Alpers M, May J, Meyer C, Kremsner PG, Am J Trop Med Hyg 1999 61 776 779 10586911
106. Association of adhesion molecule PECAM-1/CD31 polymorphism with susceptibility to cerebral malaria in Thais. Kikuchi M, Looareesuwan S, Ubalee R, Tasanor O, Suzuki F, Wattanagoon Y, Na-Bangchang K, Kimura A, Aikawa M, Hirayama K, Parasitol Int 2001 50 235 239 10.1016/S1383-5769(01)00082-4 11719109 (Pubitemid 33062369)
107. Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. Shi YP, Nahlen BL, Kariuki S, Urdahl KB, McElroy PD, Roberts JM, Lal AA, J Infect Dis 2001 184 107 111 10.1086/320999 11398118 (Pubitemid 32568509)
108. CD40L association with protection from severe malaria. Sabeti P, Usen S, Farhadian S, Jallow M, Doherty T, Newport M, Pinder M, Ward R, Kwiatkowski D, Genes Immun 2002 3 286 291 10.1038/sj.gene.6363877 12140747 (Pubitemid 38967554)
109. CD36 polymorphism is associated with protection from cerebral malaria. Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, Looareesuwan S, Tokunaga K, Am J Hum Genet 2003 72 364 374 10.1086/346091 12506336 (Pubitemid 36194245)
110. Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Gyan BA, Goka B, Cvetkovic JT, Kurtzhals JL, Adabayeri V, Perlmann H, Lefvert AK, Akanmori BD, Troye-Blomberg M, Clin Exp Immunol 2004 138 145 150 10.1111/j.1365-2249.2004. 02590.x 15373917 (Pubitemid 39279977)
111. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB, Infect Immun 2004 72 5630 5637 10.1128/IAI.72.10.5630-5637.2004 15385460 (Pubitemid 39303671)
112. IL4-589 C/T polymorphism and IgE levels in severe malaria. Verra F, Luoni G, Calissano C, Troye-Blomberg M, Perlmann P, Perlmann H, Arca B, Sirima BS, Konate A, Coluzzi M, Kwiatkowski D, Modiano D, Acta Trop 2004 90 205 209 10.1016/j.actatropica.2003.11.014 15177147 (Pubitemid 38283770)
113. Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. Leoratti FM, Farias L, Alves FP, Suarez-Mutis MC, Coura JR, Kalil J, Camargo EP, Moraes SL, Ramasawmy R, J Infect Dis 2008 198 772 780 10.1086/590440 18662133
114. Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Sinha S, Mishra SK, Sharma S, Patibandla PK, Mallick PK, Sharma SK, Mohanty S, Pati SS, Mishra SK, Ramteke BK, Bhatt R, Joshi H, Dash AP, Ahuja RC, Awasthi S, Venkatesh V, Habib S, Malar J 2008 7 13 10.1186/1475-2875-7-13 18194515 (Pubitemid 351270258)
115. Haplotype specific-sequencing reveals MBL2 association with asymptomatic Plasmodium falciparum infection. Boldt AB, Messias-Reason IJ, Lell B, Issifou S, Pedroso ML, Kremsner PG, Kun JF, Malar J 2009 8 97 10.1186/1475-2875-8-97 19432958
116. Genetic susceptibility to malaria getting complex. Kwiatkowski D, Curr Opin Genet Dev 2000 10 320 324 10.1016/S0959-437X(00)00087-3 10826994 (Pubitemid 30307253)
117. Associations between the IL-4-590 T allele and Plasmodium falciparum infection prevalence in asymptomatic Fulani of Mali. Vafa M, Maiga B, Berzins K, Hayano M, Bereczky S, Dolo A, Daou M, Arama C, Kouriba B, Farnert A, Doumbo OK, Troye-Blomberg M, Microbes Infect 2007 9 1043 1048 10.1016/j.micinf.2007.04.011 17662633 (Pubitemid 47299212)
118. Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren. Mombo LE, Ntoumi F, Bisseye C, Ossari S, Lu CY, Nagel RL, Krishnamoorthy R, Am J Trop Med Hyg 2003 68 186 190 12641410 (Pubitemid 38240544)
119. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, Newbold CI, Greenwood BM, Marsh K, Hill AVS, Nature 1995 376 246 249 10.1038/376246a0 7617034
120. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Modiano D, Luoni G, Sirima BS, Simpore J, Verra F, Konate A, Rastrelli E, Olivieri A, Calissano C, Paganotti GM, D'Urbano L, Sanou I, Sawadogo A, Modiano G, Coluzzi M, Nature 2001 414 305 308 10.1038/35104556 11713529 (Pubitemid 33097806)
121. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P. falciparum malaria. Chotivanich K, Udomsangpetch R, Pattanapanyasat K, Chierakul W, Simpson J, Looareesuwan S, White N, Blood 2002 100 1172 1176 12149194 (Pubitemid 34864268)
122. Malaria resistance genes: a natural selection. Hill AV, Trans R Soc Trop Med Hyg 1992 86 225 226 232 10.1016/0035-9203(92)90282-H 1412635
123. Ovalocytosis and cerebral malaria. Genton B, al-Yaman F, Mgone CS, Alexander N, Paniu MM, Alpers MP, Mokela D, Nature 1995 378 564 565 10.1038/378564a0 8524388
124. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Cockburn IA, Mackinnon MJ, O'Donnell A, Allen SJ, Moulds JM, Baisor M, Bockarie M, Reeder JC, Rowe JA, Proc Natl Acad Sci USA 2004 101 272 277 10.1073/pnas.0305306101 14694201 (Pubitemid 38084240)
125. Red blood cell polymorphisms in relation to Plasmodium falciparum asymptomatic parasite densities and morbidity in Senegal. Migot-Nabias F, Pelleau S, Watier L, Guitard J, Toly C, De Araujo C, Ngom MI, Chevillard C, Gaye O, Garcia A, Microbes Infect 2006 8 2352 2358 10.1016/j.micinf.2006.03.021 16859949 (Pubitemid 44499042)
126. Adaptation of Plasmodium falciparum to glucose 6-phosphate dehydrogenase-deficient host red cells by production of parasite-encoded enzyme. Usanga EA, Luzzatto L, Nature 1985 313 793 795 10.1038/313793a0 3883193 (Pubitemid 15130828)
127. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, Kone A, Diallo DA, Raza A, Kai O, Marsh K, Plowe CV, Doumbo OK, Moulds JM, Proc Natl Acad Sci USA 2007 104 17471 17476 10.1073/pnas.0705390104 17959777 (Pubitemid 350219862)
128. Short report: severe malaria associated with blood group. Fischer PR, Boone P, Am J Trop Med Hyg 1998 58 122 123 9452303 (Pubitemid 28071421)
129. The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Lell B, May J, Schmidt-Ott RJ, Lehman LG, Luckner D, Greve B, Matousek P, Schmid D, Herbich K, Mockenhaupt FP, Meyer CG, Bienzle U, Kremsner PG, Clin Infect Dis 1999 28 794 799 10.1086/515193 10825041 (Pubitemid 29169418)
130. Blood group A antigen is a coreceptor in Plasmodium falciparum rosetting. Barragan A, Kremsner PG, Wahlgren M, Carlson J, Infect Immun 2000 68 2971 2975 10.1128/IAI.68.5.2971-2975.2000 10768996 (Pubitemid 30253879)
131. Plasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay Cohort Project. Branch OH, Takala S, Kariuki S, Nahlen BL, Kolczak M, Hawley W, Lal AA, Infect Immun 2001 69 7783 7792 10.1128/IAI.69.12.7783-7792.2001 11705960 (Pubitemid 33086609)
132. The genome sequence of the malaria mosquito Anopheles gambiae. Holt RA, Subramanian GM, Halpern A, Sutton GG, Charlab R, Nusskern DR, Wincker P, Clark AG, Ribeiro JM, Wides R, Salzberg SL, Loftus B, Yandell M, Majoros WH, Rusch DB, Lai Z, Kraft CL, Abril JF, Anthouard V, Arensburger P, Atkinson PW, Baden H, de Berardinis V, Baldwin D, Benes V, Biedler J, Blass C, Bolanos R, Boscus D, Barnstead M, Cai S, Center A, Chaturverdi K, Christophides GK, Chrystal MA, Clamp M, Cravchik A, Curwen V, Dana A, Delcher A, Dew I, Evans CA, Flanigan M, Grundschober-Freimoser A, Friedli L, Gu Z, Guan P, Guigo R, Hillenmeyer ME, Hladun SL, Hogan JR, Hong YS, Hoover J, Jaillon O, Ke Z, Kodira C, Kokoza E, Koutsos A, Letunic I, Levitsky A, Liang Y, Lin JJ, Lobo NF, Lopez JR, Malek JA, McIntosh TC, Meister S, Miller J, Mobarry C, Mongin E, Murphy SD, O'Brochta DA, Pfannkoch C, Qi R, Regier MA, Remington K, Shao H, Sharakhova MV, Sitter CD, Shetty J, Smith TJ, Strong R, Sun J, Thomasova D, Ton LQ, Topalis P, Tu Z, Unger MF, Walenz B, Wang A, Wang J, Wang M, Wang X, Woodford KJ, Wortman JR, Wu M, Yao A, Zdobnov EM, Zhang H, Zhao Q, Zhao S, Zhu SC, Zhimulev I, Coluzzi M, della Torre A, Roth CW, Louis C, Kalush F, Mural RJ, Myers EW, Adams MD, Smith HO, Broder S, Gardner MJ, Fraser CM, Birney E, Bork P, Brey PT, Venter JC, Weissenbach J, Kafatos FC, Collins FH, Hoffman SL, Science 2002 298 129 149 10.1126/science.1076181 12364791
133. The immunology of malaria infection. Plebanski M, Hill AV, Curr Opin Immunol 2000 12 437 441 10.1016/S0952-7915(00)00117-5 10899022 (Pubitemid 30410350)
134. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P, J Exp Med 1990 172 1633 1641 10.1084/jem.172.6.1633 2258697
135. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Groux H, Gysin J, Res Immunol 1990 141 529 542 10.1016/0923-2494(90)90021-P 1704637 (Pubitemid 20377037)
136. Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria. Sarthou JL, Angel G, Aribot G, Rogier C, Dieye A, Toure Balde A, Diatta B, Seignot P, Roussilhon C, Infect Immun 1997 65 3271 3276 9234786 (Pubitemid 27342410)
137. Natural human IgG subclass antibodies to Plasmodium falciparum blood stage antigens and their relation to malaria resistance in an endemic area of Thailand. Tangteerawatana P, Krudsood S, Chalermrut K, Looareesuwan S, Khusmith S, Southeast Asian J Trop Med Public Health 2001 32 247 254 11556572 (Pubitemid 33641772)
138. Differential regulation of IgG subclasses and IgE antimalarial antibody responses in complicated and uncomplicated Plasmodium falciparum malaria. Tangteerawatana P, Montgomery SM, Perlmann H, Looareesuwan S, Troye-Blomberg M, Khusmith S, Parasite Immunol 2007 29 475 483 10.1111/j.1365-3024.2007.00965.x 17727571 (Pubitemid 47313231)
139. Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India. Lucchi NW, Tongren JE, Jain V, Nagpal AC, Kauth CW, Woehlbier U, Bujard H, Dash AP, Singh N, Stiles JK, Udhayakumar V, Malar J 2008 7 121 10.1186/1475-2875-7-121 18601721
140. Plasmodium-specific immunoglobulin E in sera from an area of holoendemic malaria. Desowitz RS, Trans R Soc Trop Med Hyg 1989 83 478 479 10.1016/0035-9203(89)90254-X 2694483 (Pubitemid 19212060)
141. Immunologic responses to soluble exoantigens of Plasmodium falciparum in Gabonese children exposed to continuous intense infection. Luty AJ, Mayombo J, Lekoulou F, Mshana R, AmJTrop Med Hyg 1994 51 720 729
142. Different antibody- and cytokine-mediated responses to Plasmodium falciparum parasite in two sympatric ethnic tribes living in Mali. Farouk SE, Dolo A, Bereczky S, Kouriba B, Maiga B, Farnert A, Perlmann H, Hayano M, Montgomery SM, Doumbo OK, Troye-Blomberg M, Microbes Infect 2005 7 110 117 10.1016/j.micinf.2004.09.012 15716067 (Pubitemid 40431350)
143. IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Perlmann H, Helmby H, Hagstedt M, Carlson J, Larsson PH, Troye-Blomberg M, Perlmann P, Clin Exp Immunol 1994 97 284 292 8050178 (Pubitemid 24263072)
144. Malaria research: host-parasite interactions and new developments in chemotherapy, immunology and vaccinology. Perlmann P, Bjorkman A, Curr Opin Infect Dis 2000 13 431 443 10.1097/00001432-200010000-00002 11964811
145. IgE and tumor necrosis factor in malaria infection. Perlmann P, Perlmann H, ElGhazali G, Blomberg MT, Immunol Lett 1999 65 29 33 10.1016/S0165-2478(98) 00120-5 10065623 (Pubitemid 29074496)
146. Contrasting functions of IgG and IgE antimalarial antibodies in uncomplicated and severe Plasmodium falciparum malaria. Perlmann P, Perlmann H, Looareesuwan S, Krudsood S, Kano S, Matsumoto Y, Brittenham G, Troye-Blomberg M, Aikawa M, Am J Trop Med Hyg 2000 62 373 377 11037780
147. Helminth infections are associated with protection from malaria-related acute renal failure and jaundice in Thailand. Nacher M, Singhasivanon P, Silachamroon U, Treeprasertsuk S, Vannaphan S, Traore B, Gay F, Looareesuwan S, Am J Trop Med Hyg 2001 65 834 836 11791982 (Pubitemid 34049480)
148. Worms can worsen malaria: towards a new means to roll back malaria? Druilhe P, Tall A, Sokhna C, Trends Parasitol 2005 21 359 362 10.1016/j.pt.2005.06.011 15967721 (Pubitemid 40968136)
149. Helminth parasites - masters of regulation. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE, Immunol Rev 2004 201 89 116 10.1111/j.0105-2896.2004.00191.x 15361235 (Pubitemid 39318446)
150. Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. Andrade BB, Santos CJ, Camargo LM, Souza-Neto SM, Reis-Filho A, Clarencio J, Mendonca VR, Luz NF, Camargo EP, Barral A, Silva AA, Barral-Netto M, PLoS One 2011 6 19841 10.1371/journal.pone.0019841 21625634
151. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Djimde AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV, AmJTrop Med Hyg 2003 69 558 563 (Pubitemid 38248261)
152. Age-dependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. Baird JK, Masbar S, Basri H, Tirtokusumo S, Subianto B, Hoffman SL, J Infect Dis 1998 178 592 595 10.1086/517482 9697752 (Pubitemid 28347954)
153. Age as a risk factor for severe Plasmodium falciparum malaria in nonimmune patients. Schwartz E, Sadetzki S, Murad H, Raveh D, Clin Infect Dis 2001 33 1774 1777 10.1086/322522 11641827 (Pubitemid 33044547)
154. Frequency of cytokine-producing T cells in patients of different age groups with Plasmodium falciparum malaria. Winkler S, Willheim M, Baier K, Schmid D, Aichelburg A, Graninger W, Kremsner PG, J Infect Dis 1999 179 209 216 10.1086/314571 9841841 (Pubitemid 29028357)
155. Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites. Kumaratilake LM, Ferrante A, Jaeger T, Rzepczyk CM, Infect Immun 1992 60 3731 3738 1500183
156. Epidemiology and burden of malaria in pregnancy. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD, Lancet Infect Dis 2007 7 93 104 10.1016/S1473-3099(07)70021-X 17251080 (Pubitemid 46123132)
157. Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria. Rogerson SJ, Wijesinghe RS, Meshnick SR, Lancet Infect Dis 2010 10 51 59 10.1016/S1473-3099(09)70322-6 20129149
158. Maternal antibodies block malaria. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE, Nature 1998 395 851 852 10.1038/27570 9804416 (Pubitemid 28503415)
159. Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant women. Wilson NO, Bythwood T, Solomon W, Jolly P, Yatich N, Jiang Y, Shuaib F, Adjei AA, Anderson W, Stiles JK, Infect Dis Obstet Gynecol 2010 2010
160. Sex in Plasmodium: a sign of commitment. Dixon MW, Thompson J, Gardiner DL, Trenholme KR, Trends Parasitol 2008 24 168 175 10.1016/j.pt.2008.01.004 18342574
161. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akim IN, Beier JC, Githure JI, Sauerwein RW, Malar J 2004 3 18 10.1186/1475-2875-3- 18 15202944 (Pubitemid 39319755)
162. Attributable fraction estimates and case definitions for malaria in endemic areas. Smith T, Schellenberg JA, Hayes R, Stat Med 1994 13 2345 2358 10.1002/sim.4780132206 7855468 (Pubitemid 24354857)
163. A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. von Seidlein L, Bojang K, Jones P, Jaffar S, Pinder M, Obaro S, Doherty T, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, McAdam K, Greenwood B, Am J Trop Med Hyg 1998 58 638 644 9598454 (Pubitemid 28237264)
164. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, Coleman R, Pinder M, Walraven G, Targett GA, PLoS Med 2005 2 92 10.1371/journal.pmed.0020092 15839740 (Pubitemid 40721079)
165. Effects of artemisinin derivatives on malaria transmissibility. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, Lancet 1996 347 1654 1658 10.1016/S0140-6736(96)91488-9 8642959 (Pubitemid 26177386)
166. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, Sauerwein RW, J Infect Dis 2006 193 1151 1159 10.1086/503051 16544256
167. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Drakeley CJ, Jawara M, Targett GA, Walraven G, Obisike U, Coleman R, Pinder M, Sutherland CJ, Trop Med Int Health 2004 9 53 61 10.1046/j.1365-3156.2003.01169.x 14728607 (Pubitemid 38178012)
168. Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Ogutu B, Tiono AB, Makanga M, Premji Z, Gbadoe AD, Ubben D, Marrast AC, Gaye O, Malar J 2010 9 30 10.1186/1475-2875-9-30 20096111
169. Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Stepniewska K, White NJ, Antimicrob Agents Chemother 2008 52 1589 1596 10.1128/AAC.00903-07 18299409 (Pubitemid 351614647)
170. Antimalarial drugs and the mosquito transmission of Plasmodium. Butcher GA, Int J Parasitol 1997 27 975 987 10.1016/S0020-7519(97)00079-9 9363480 (Pubitemid 27423685)
171. Antimalarial drug toxicity: a review. Taylor WR, White NJ, Drug Saf 2004 27 25 61 14720085 (Pubitemid 38186936)
172. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ, Antimicrob Agents Chemother 2004 48 1329 1334 10.1128/AAC.48.4.1329-1334.2004 15047537 (Pubitemid 38405489)
173. A safety and efficacy trial of artesunate, sulphadoxine-pyrimethamine and primaquine in P. falciparum malaria. Weerasinghe KL, Galappaththy G, Fernando WP, Wickremasinghe DR, Faizal HM, Wickremasinghe AR, Ceylon Med J 2002 47 83 85 12449772
174. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T, PLoS One 2007 2 1023 10.1371/journal.pone.0001023 17925871 (Pubitemid 351486737)
175. Reductions in malaria and anaemia case and death burden at hospitals following scale-up of malaria control in Zanzibar, 1999-2008. Aregawi MW, Ali AS, Al-mafazy AW, Molteni F, Katikiti S, Warsame M, Njau RJ, Komatsu R, Korenromp E, Hosseini M, Low-Beer D, Bjorkman A, D'Alessandro U, Coosemans M, Otten M, Malar J 2011 10 46 10.1186/1475-2875-10-46 21332989
176. Mosquitoes, malaria and man: a history of hostilities since 1880, John Murray, London. Harrison G, 1978 172 174
177. Field evaluation of the ICT Malaria Pf/Pv immunochromatographic test for the detection of asymptomatic malaria in a Plasmodium falciparum/vivax endemic area in Thailand. Coleman RE, Maneechai N, Rachapaew N, Kumpitak C, Soyseng V, Miller RS, Thimasarn K, Sattabongkot J, AmJTrop Med Hyg 2002 66 379 383 (Pubitemid 34810490)